‘Tepid’ response to CRISPR embryo editing could lead to regulations, Gottlieb says

The scientific community’s response to reports of human germline editing by Chinese researcher Jiankui He has been too little and too late, and governments may respond with heavy handed regulations, FDA Commissioner Scott Gottlieb told BioCentury. NIH Director Francis Collins released a statement calling

Read the full 448 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers